Condition: Breast Cancer · Neoadjuvant Therapy · Sentinel Lymph Node Biopsy · Sponsor: Seoul National University Hospital
NEO-NAUTILUS is a prospective, multicenter, randomized phase III clinical trial to evaluate whether omitting axillary lymph node surgery (ALND or SLNB) in clinically lymph node-negative breast cancer patients after neoadjuvant chemotherapy is non-inferior to performing SLNB in terms of 5-year disease-free survival.
This description comes directly from the study's public registry record.
Wonshik Han, MD, PhD. · 82-2-3461-6060 · hanw@snu.ac.kr
Always discuss trial participation with your own doctor first.
| Seoul National University Hopsital | Seoul, South Korea | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06704945